Mitotic Index
-
Subject Areas on Research
- "Thin" malignant melanoma: risk factors and clinical management.
- 8(S)-hydroxyeicosatetraenoic acid is the lipoxygenase metabolite of arachidonic acid that regulates epithelial cell migration in the rat cornea.
- A model for pretest probability of lymph node metastasis from cutaneous Melanoma.
- A probabilistic analysis of mitotic counts in melanoma.
- Can proliferation biomarkers reliably predict recurrence in World Health Organization 2003 defined endometrial stromal sarcoma, low grade?
- Clear cell hidradenoma: a mimic of metastatic clear cell tumors.
- Clinicopathologic correlations in the oligodendroglioma.
- Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.
- Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.
- Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
- Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma.
- Mitotic rate in melanoma: a reexamination.
- Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.
- Pathology and pathophysiology of uterine smooth-muscle tumors.
- Pretreatment cytokinetic studies in 94 children with acute leukemia. Relationship to other variables at diagnosis and to outcome of standard treatment.
- Primary malignant fibrous histiocytoma of the lung. A clinicopathologic and ultrastructural study of five cases.
- Survival of grafted fetal neural cells in kainic acid lesioned CA3 region of adult hippocampus depends upon cell specificity.
- Variation in DNA and RNA synthetic responses during activation of lymphocytes from inbred strains of mice.
- beta-Catenin is not necessary for maintenance or repair of the bronchiolar epithelium.
-
Keywords of People
- Berchuck, Andrew, James M. Ingram Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology